Cholestasis Reversal: Efficacy of IV Fish Oil (Reversal)
Sponsor: Mark Puder
This PHASE2/PHASE3 trial investigates Gastrointestinal Disease and Parenteral Nutrition Associated Liver Disease and is currently completed. Mark Puder leads this study, which shows 13 recorded versions since 2006 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Oct 2024 — Present [monthly]
Completed PHASE2/PHASE3
-
Sep 2024 — Oct 2024 [monthly]
Completed PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2_PHASE3
-
Sep 2020 — Jan 2021 [monthly]
Completed PHASE2_PHASE3
▶ Show 8 earlier versions
-
Jul 2019 — Sep 2020 [monthly]
Completed PHASE2_PHASE3
Status: Recruiting → Completed
-
Aug 2018 — Jul 2019 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2018 — Aug 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Apr 2018 — Jun 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Dec 2017 — Apr 2018 [monthly]
Recruiting PHASE2_PHASE3
-
Jun 2017 — Dec 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE2_PHASE3
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE2_PHASE3
First recorded
Aug 2006
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Mark Puder
For direct contact, visit the study record on ClinicalTrials.gov .